Christopher Poole
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, Ovarian cancer diagnosis and treatment, HER2/EGFR in Cancer Research, BRCA gene mutations in cancer
Most-Cited Works
- → Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)(2018)1,294 cited
- → Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial(2014)541 cited
- → aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.(2013)446 cited
- → First-Line Trastuzumab Plus an Aromatase Inhibitor, With or Without Pertuzumab, in Human Epidermal Growth Factor Receptor 2–Positive and Hormone Receptor–Positive Metastatic or Locally Advanced Breast Cancer (PERTAIN): A Randomized, Open-Label Phase II Trial(2018)218 cited
- → Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others(2016)213 cited
- → Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer(2007)193 cited
- → HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data(2011)191 cited
- → Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer(2006)189 cited
- → Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial(2009)188 cited
- → Inadequacy of iridium implant as sole radiation treatment for operable breast cancer(1996)177 cited